Connection

William Hrushesky to Rats

This is a "connection" page, showing publications William Hrushesky has written about Rats.
Connection Strength

0.154
  1. Cisplatin-associated anemia: an erythropoietin deficiency syndrome. J Clin Invest. 1995 Apr; 95(4):1650-9.
    View in: PubMed
    Score: 0.017
  2. Circadian cancer pharmacodynamics. Ann Ist Super Sanita. 1993; 29(4):705-10.
    View in: PubMed
    Score: 0.015
  3. Prohibitin as an oxidative stress biomarker in the eye. Int J Biol Macromol. 2010 Dec 01; 47(5):685-90.
    View in: PubMed
    Score: 0.012
  4. Determination of the therapeutic index of floxuridine by its circadian infusion pattern. J Natl Cancer Inst. 1990 Mar 07; 82(5):386-93.
    View in: PubMed
    Score: 0.012
  5. Control of a murine plasmacytoma with doxorubicin-cisplatin: dependence on circadian stage of treatment. J Natl Cancer Inst. 1989 Jan 18; 81(2):135-45.
    View in: PubMed
    Score: 0.011
  6. Methylene blue protects intestinal mucosa from free radical-mediated sublethal radiation damage. Free Radic Biol Med. 1988; 5(4):207-13.
    View in: PubMed
    Score: 0.010
  7. Cisplatin chronotherapy and disulfiram rescue reduce toxicity without interfering with anticancer activity: animal findings and preliminary clinical experiences. Chronobiol Int. 1986; 3(1):55-64.
    View in: PubMed
    Score: 0.009
  8. Cyclosporine timing and kidney damage. N Engl J Med. 1985 Jul 18; 313(3):184.
    View in: PubMed
    Score: 0.009
  9. Circadian timing of cancer chemotherapy. Science. 1985 Apr 05; 228(4695):73-5.
    View in: PubMed
    Score: 0.009
  10. Circadian toxicology of cyclosporin. Toxicol Appl Pharmacol. 1985 Jan; 77(1):181-5.
    View in: PubMed
    Score: 0.008
  11. 24-hour mean pulse. Simple predictor of doxorubicin-induced cardiac damage. Am J Med. 1984 Sep; 77(3):399-406.
    View in: PubMed
    Score: 0.008
  12. Circadian mesor of recumbent pulse--cost-effective predictor of doxorubicin-induced congestive heart failure. Chronobiol Int. 1984; 1(1):59-66.
    View in: PubMed
    Score: 0.008
  13. The clinical application of chronobiology to oncology. Am J Anat. 1983 Dec; 168(4):519-42.
    View in: PubMed
    Score: 0.008
  14. Circadian stage dependence of cis-diamminedichloroplatinum lethal toxicity in rats. Cancer Res. 1982 Mar; 42(3):945-9.
    View in: PubMed
    Score: 0.007
  15. Carcinogenicity of ethylmethanesulfonate. J Natl Cancer Inst. 1972 Oct; 49(4):1077-83.
    View in: PubMed
    Score: 0.004
  16. Hormonal and chemotherapeutic treatment of prostatic carcinoma; Dunning adenocarcinoma of the prostate in Copenhagen-Fischer rats. Oncology. 1985; 42(1):48-54.
    View in: PubMed
    Score: 0.002
  17. Cisplatin urinary pharmacokinetics and nephrotoxicity: a common circadian mechanism. Cancer Treat Rep. 1982 Nov; 66(11):1933-8.
    View in: PubMed
    Score: 0.002
  18. Lethal nephrotoxicity and hematologic toxicity of cis-diamminedichloroplatinum ameliorated by optimal circadian timing and hydration. Eur J Cancer Clin Oncol. 1982 May; 18(5):471-7.
    View in: PubMed
    Score: 0.002
  19. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing. Cancer Res. 1982 Mar; 42(3):950-5.
    View in: PubMed
    Score: 0.002
  20. Influence of hormone therapy on rats treated with the carcinogen ethylmethanesulphonate. Res Commun Chem Pathol Pharmacol. 1974 Jan; 7(1):25-30.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.